PROFILES - Connect with RTRN Researchers

Irma Febo
Title Associate Professor
Faculty Rank Associate Professor
Degree MD
Institution University of Puerto Rico
Department Pediatrics
Clusters HIV/AIDS
Address
UPR-Medical Sciences Campus
School of Medicine
P.O. Box 365067
City San Juan
State PR
Postal Code 00936-5067
Telephone (787)756-4020
Fax
Email
QR Barcode

Narrative icon

  Area of Expertise: AIDS.

NIH Awarded Grants icon

  Research projects funded by the National Institutes of Health (NIH), the Centers for Disease Control (CDC), the Food and Drug Administration (FDA), and the Department of Veterans Affairs (VA)

Loading
Please wait
1.
2010Adolescent Medicine Trials Unit for HIV/AIDS Interventi*5U01HD040490-10
2.
2009Adolescent Medicine Trials Unit for HIV/AIDS Interventi*5U01HD040490-09
3.
2008Adolescent Medicine Trials Unit for HIV/AIDS Interventi*5U01HD040490-08
4.
2007Adolescent Medicine Trials Unit for HIV/AIDS Interventi*5U01HD040490-07
5.
2006UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT5U01AI032906-14
6.
2006IMPACT OF DISCLOSURE OF HIV DIAGNOSIS5P20RR011126-12
7.
2006Adolescent Medicine Trials Unit for HIV/AIDS Interventi*2U01HD040490-06
8.
2005UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT5U01AI032906-13
9.
2005ADOLESCENT MEDICINE TRIALS NETWORK UNIT FOR HIV/AIDS5U01HD040490-05
10.
2004UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT5U01AI032906-12
11.
2004ADOLESCENT MEDICINE TRIALS NETWORK UNIT FOR HIV/AIDS5U01HD040490-04
12.
2004UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT3U01AI032906-12S1
13.
2003UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT5U01AI032906-11
14.
2003ADOLESCENT MEDICINE TRIALS NETWORK UNIT FOR HIV/AIDS5U01HD040490-03
15.
2002ADOLESCENT MEDICINE TRIALS NETWORK UNIT FOR HIV/AIDS5U01HD040490-02
16.
2002UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT2U01AI032906-10
17.
2001UNIVERSITY OF P.R., PEDIATRIC AIDS CLINICAL TRIALS UNIT3U01AI032906-09S1
18.
2001ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS1U01HD040490-01
19.
2000UNIVERSITY OF P.R., PEDIATRIC AIDS CLINICAL TRIALS UNIT5U01AI032906-09
20.
1999UNIVERSITY OF P.R., PEDIATRIC AIDS CLINICAL TRIALS UNIT5U01AI032906-08

Publications icon

  Check NIH Public Access Policy Compliance

Loading
Please wait
1. Diaz C, Lin L, Martinez LJ, Eckels KH, Campos M, Jarman RG, De La Barrera R, Lepine E, Toussaint JF, Febo I, Innis BL, Thomas SJ, Schmidt AC. Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico. Am J Trop Med Hyg. 2018 Mar 05.
2. Bauermeister JA, Giguere R, Leu CS, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men. AIDS Behav. 2018 Feb; 22(2):412-420.
3. Ortiz AP, Tamayo V, Scorsone A, Soto-Salgado M, Febo I, Piovanetti P, Venegas-Ríos HL, Yamamura Y, Zorrilla C. Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women. Papillomavirus Res. 2017 Dec; 4:39-44.
4. Bauermeister J, Giguere R, Leu CS, Febo I, Cranston R, Mayer K, Carballo-Diéguez A. Interactive Voice Response System: Data Considerations and Lessons Learned During a Rectal Microbicide Placebo Adherence Trial for Young Men Who Have Sex With Men. J Med Internet Res. 2017 Jun 09; 19(6):e207.
5. Giguere R, Frasca T, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. Acceptability of Three Novel HIV Prevention Methods Among Young Male and Transgender Female Sex Workers in Puerto Rico. AIDS Behav. 2016 Oct; 20(10):2192-2202.
6. Romas L, Birse K, Mayer KH, Abou M, Westmacott G, Giguere R, Febo I, Cranston RD, Carballo-Diéguez A, McGowan I, Burgener A. Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression. AIDS Res Hum Retroviruses. 2016 Oct/Nov; 32(10-11):1005-1015.
7. McGowan I, Cranston RD, Mayer KH, Febo I, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Park SY, Brand RM, Jacobson C, Giguere R, Dolezal C, Frasca T, Leu CS, Schwartz JL, Carballo-Diéguez A. Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women. PLoS One. 2016; 11(6):e0158310.
8. Frasca T, Giguere R, Ibitoye M, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse. Arch Sex Behav. 2017 May; 46(4):1101-1109.
9. Bauermeister J, Giguere R, Dolezal C, Leu CS, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men. AIDS Educ Prev. 2016 Feb; 28(1):1-10.
10. Silva-Suárez G, Bastida E, Rabionet SE, Beck-Sagué C, Febo I, Zorrilla CD. "That's True Love:" Lived Experiences of Puerto Rican Perinatally HIV-Infected Youth within Their Families' Context. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010007.
11. Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, Mayer KH, McGowan I, Carballo-Diéguez A. Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev. 2015 Aug; 27(4):289-97.
12. Giguere R, Dolezal C, Bauermeister JA, Frasca T, Valladares J, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico. J Sex Res. 2016 Jul-Aug; 53(6):633-41.
13. Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Rivera Torres CM, Chutuape KS, Stines SJ, Straub DM, Peralta L, Febo I, Hightow-Weidman L, Gonin R, Kapogiannis BG, Ellen JM. A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection. J Adolesc Health. 2014 Dec; 55(6):765-73.
14. Carballo-Diéguez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Frasca T, Labbett R, Cranston RD, Febo I, Mayer K, McGowan I. Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research. AIDS Behav. 2014 Sep; 18(9):1726-33.
15. Carballo-Diéguez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Rohan LC, Anton PA, Cranston RD, Febo I, Mayer K, McGowan I. Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally. AIDS Behav. 2014 Sep; 18(9):1734-45.
16. McGowan I, Gomez K, Bruder K, Febo I, Chen BA, Richardson BA, Husnik M, Livant E, Price C, Jacobson C. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS. 2011 May 15; 25(8):1057-64.
17. Ortega-García JA, López-Hernández FA, Sobrino-Najul E, Febo I, Fuster-Soler JL. [Environment and paediatric cancer in the Region of Murcia (Spain): integrating clinical and environmental history in a geographic information system]. An Pediatr (Barc). 2011 Apr; 74(4):255-60.
18. Read JS, Best BM, Stek AM, Hu C, Capparelli EV, Holland DT, Burchett SK, Smith ME, Sheeran EC, Shearer WT, Febo I, Mirochnick M. Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum. HIV Med. 2008 Nov; 9(10):875-82.
19. Zorrilla CD, Tamayo Agrait V, Febo I, Santiago LE, Díaz C, Salabarría I, Pérez E, Hillyer GV. Reduction in the perinatal HIV transmission: the experience at the Maternal Infant Studies Center and Gamma Projects at the University of Puerto Rico School of Medicine. P R Health Sci J. 2007 Dec; 26(4):329-35.
20. Blasini I, Chantry C, Cruz C, Ortiz L, Salabarría I, Scalley N, Matos B, Febo I, Díaz C. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr. 2004 Jun; 25(3):181-9.
21. Hillyer GV, Febo I, Díaz C. The rapid diagnosis of HIV-1 infection in mothers in Puerto Rico: a crucial testing strategy for maximal reduction of perinatal transmission. P R Health Sci J. 2002 Jun; 21(2):133-5.
22. Sanchez-Carrasquillo E, García V, Rivera CE, Febo I, Melendez-Guerrero LM. CCR5 and beta-chemokines in HIV-1 infected children. P R Health Sci J. 2000 Dec; 19(4):345-51.
23. Rodriguez Orengo JF, Santana J, Febo I, Diaz C, Rodriguez JL, Garcia R, Font E, Rosario O. Intracellular studies of the nucleoside reverse transcriptase inhibitor active metabolites: a review. P R Health Sci J. 2000 Mar; 19(1):19-27.
24. Chantry CJ, Rodríguez JL, Febo I, Díaz C, Rodriguez-Orengo JF. Plasma glutathione concentrations in non-infected infants born from HIV-infected mothers: developmental profile. P R Health Sci J. 1999 Sep; 18(3):267-72.
25. Rodriguez JF, Cordero J, Chantry C, González S, Rivera C, Febo I, Colón A, Díaz C. Plasma glutathione concentrations in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1998 Mar; 17(3):236-41.

Research Resources icon

Funding Opportunities icon

Browse active NIH & NSF funding opportunities, requests for applications (RFAs), and program announcements (PAs)

Publications Timeline

Top MeSH Keywords

Tree Map of Keyword Semantic Groups (Categories)

Left-click a node to move down the tree, right-click the graph to move back up the tree

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
 
Keyword
Last Name
Institution
 
See all (8) people See all (60) people Search for (7) people
Feedback

RTRN Collaboration and Professional Networking Feedback